214390.KS · 경보제약
South Korea · RS rating 50 · As of 2026-10-14
| Price | 5,280.00 KRW |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 52 / 55 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 25 / 42 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +663.6% |
| Sales growth Q/Q | +13.8% |
| Distance from 52-week high | +38.2% |
| Market cap (USD) | $97.9M |